Parabilis Medicines

PBLS

Parabilis Medicines develops helical peptide therapeutics targeting intracellular proteins to treat various cancers and serious diseases for patients with unmet medical needs.

Bicycle Therapeutics

This biopharmaceutical company develops synthetic bicyclic peptide medicines to treat solid tumours and other diseases for patients with unmet medical needs.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

TORL BioTherapeutics

This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Frontier Medicines

This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.

Momentous Therapeutics

This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.

Amphista Therapeutics

This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.